Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.
FDA
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Posted inNeuroscience, New Drugs, Regulatory
Auvelity: New Antidepressant for Most Severe Depression
Dextromethorphan and bupropion: A powerful drug combination that will help with depression that cannot be treated with standard antidepressants.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Zoryve: New Effective Cream for Psoriasis
Roflumilast will cure plaque psoriasis in half of patients.
Posted inNew Drugs, Regulatory
Vuity: First Pharmacological Treatment for Presbyopia
Pilocarpine by Allergan and AbbVie is the first drug for age-related farsightedness.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Opzelura: New Treatment for Vitiligo
Ruxolitinib cream will help most patients treat nonsegmental vitiligo.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19
Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.